Neonatology

Original Paper

A Randomized Trial of Low-Flow Oxygen versus Nasal Continuous Positive Airway Pressure in Preterm Infants

Heiring C.a · Steensberg J.b · Bjerager M.c · Greisen G.a

Author affiliations

Departments of aNeonatology and bPediatric Cardiology, Rigshospitalet, Copenhagen, and cDepartment of Pediatrics, Nordsjællands Hospital, Hillerød, Denmark

Related Articles for ""

Neonatology 2015;108:259-265

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: January 31, 2015
Accepted: June 25, 2015
Published online: August 28, 2015
Issue release date: November 2015

Number of Print Pages: 7
Number of Figures: 1
Number of Tables: 4

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO

Abstract

Background: Nasal continuous positive airway pressure (nCPAP) stabilizes the residual volume and may decrease the risk of ‘atelectotrauma', potentially promoting lung development in neonates. Objectives: To assess whether replacing nCPAP by low-flow O2 by nasal cannula affects lung function expressed as the arterial/alveolar oxygen tension ratio (a/A pO2 ratio) on postnatal day 28. Methods: Preterm infants (birth weight <1,500 g and gestational age, GA >26 + 0 weeks) stable on nCPAP between postnatal days 4 and 7 were randomized to nCPAP or low-flow O2 by nasal cannula (<0.2 liters/min). Study criteria defined how to wean/restart respiratory support or change from low-flow O2 to nCPAP and vice versa. Transcutaneous monitoring was used for the assessment of the a/A pO2 ratio on day 28 using a head box for all infants for accurate measurement and to eliminate possible effects from nCPAP or low-flow O2 on oxygen requirement. Results: We enrolled 52 infants (nCPAP group n = 30 and low-flow O2 group n = 22). The a/A pO2 ratio at 28 days was 0.43 ± 0.17 (nCPAP group) versus 0.48 ± 0.18 (p = 0.36). The duration of nCPAP was 16.4 (low-flow group) versus 41.1 days (nCPAP group), p < 0.001. There was no difference between groups in the fraction needing any respiratory support at 36 weeks' corrected age, length of stay, weight at discharge, and relative weight gain. Conclusions: Replacing nCPAP by low-flow O2 in preterm infants with GA >26 weeks at the end of the first week of life did not seem to affect the a/A pO2 ratio or weight gain negatively. Thus, prolonged nCPAP seems not to have a positive effect on lung function at 28 days of life and replacement by low-flow O2 could reduce the cost of equipment and increase the ease of nursing.

© 2015 S. Karger AG, Basel




Related Articles:


References

  1. Avery ME, Tooley WH, Keller JB, Hurd SS, Bryan MH, Cotton RB, Epstein MF, Fitzhardinge PM, Hansen CB, Hansen TN: Is chronic lung disease in low birth weight infants preventable? A survey of eight centers. Pediatrics 1987;79:26.
  2. Davis P, Henderson-Smart D: Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev 2003;2:CD000143.
  3. Subramaniam P, Henderson-Smart DJ, Davis PG: Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst Rev 2005;3:CD001243.
  4. Verder H, Bohlin K, Kamper J, Lindwall R, Jonsson B: Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia. Acta Paediatr 2009;98:1400-1408.
  5. Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Plavka R, Saugstad OD, Simeoni U, Speer CP, Vento M, Halliday HL; European Association of Perinatal Medicine: European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants - 2013 update. Neonatology 2013;103:353-368.
  6. Jardine L, Davies MW: Withdrawal of neonatal continuous positive airway pressure: current practice in Australia. Pediatr Int 2008;50:572-575.
  7. Jardine LA, Inglis G, Davies MW: Strategies for the withdrawal of nasal continuous positive airway pressure (NCPAP) in preterm infants. Cochrane Database Syst Rev 2011;16:CD006979.
  8. Rastogi S, Wong W, Gupta A, Bhutada A: Deepa Rastogi, Maimonides Neonatal G: Gradual versus sudden weaning from nasal CPAP in preterm infants: a pilot randomized controlled trial. Respir Care 2013;58:511-516.
  9. O'Donnell SM, Curry SJ, Buggy NA, Moynihan MM, Sebkova S, Janota J, Miletin J: The NOFLO trial: low-flow nasal prongs therapy in weaning nasal continuous positive airway pressure in preterm infants. J Pediatr 2013;163:79-83.
  10. Abdel-Hady H, Shouman B, Aly H: Early weaning from CPAP to high flow nasal cannula in preterm infants is associated with prolonged oxygen requirement: a randomized controlled trial. Early Hum Dev 2011;87:205-208.
  11. Sasi A, Malhotra A: High flow nasal cannula for continuous positive airway pressure weaning in preterm neonates: a single-centre experience. J Paediatr Child Health 2015;51:199-203.
  12. Fernandez-Alvarez JR, Gandhi RS, Amess P, Mahoney L, Watkins R, Rabe H: Heated humidified high-flow nasal cannula versus low-flow nasal cannula as weaning mode from nasal CPAP in infants ≤28 weeks of gestation. Eur J Pediatr 2014;173:93-98.
  13. Broom M, Ying L, Wright A, Stewart A, Abdel-Latif ME, Shadbolt B, Todd DA: Ceasing CPAP at Standard Criteria (CICADA): impact on weight gain, time to full feeds and caffeine use. Arch Dis Child Fetal Neonatal Ed 2014;99:F423-F425.
  14. Todd DA, Wright A, Broom M, Chauhan M, Meskell S, Cameron C, Perdomi AM, Rochefort M, Jardine L, Stewart A, Shadbolt B: Methods of weaning preterm babies <30 weeks gestation off CPAP: a multicentre randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2012;97:F236-F240.
  15. Gilbert R, Keighley JF: The arterial-alveolar oxygen tension ratio. An index of gas exchange applicable to varying inspired oxygen concentrations. Am Rev Respir Dis 1974;109:142-145.
  16. Benveniste D, Berg O, Poul Pedersen J: A technique for delivery of continuous positive airway pressure to the neonate. J Pediatr 1976;88:1015-1019.
  17. Wimberley PD, Frederiksen PS, Witt-Hansen J, Melberg SG, Friis-Hansen B: Evaluation of a transcutaneous oxygen and carbon dioxide monitor in a neonatal intensive care department. Acta Paediatr 1985;74:352-359.
  18. Wimberley PD, Friis-Hansen B: The use of TcpO2 monitoring in neonatal intensive care. Dan Med Bull 1981;28:37-40.
  19. Verder H, Albertsen P, Ebbesen F, Greisen G, Robertson B, Bertelsen A, Agertoft L, Djernes B, Nathan E, Reinholdt J: Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation. Pediatrics 1999;103:E24.
  20. Subhedar NV, Tan AT, Sweeney EM, Shaw NJ: A comparison of indices of respiratory failure in ventilated preterm infants. Arch Dis Child Fetal Neonatal Ed 2000;83:F97-F100.
  21. Marsal K, Persson PH, Larsen T, Lilja H, Selbing A, Sultan B: Intrauterine growth curves based on ultrasonically estimated foetal weights. Acta Paediatr 1996;85:843-848.
  22. Abdel-Hady H, Mohareb S, Khashaba M, Abu-Alkhair M, Greisen G: Randomized controlled trial of discontinuation of nasal-CPAP in stable preterm infants breathing room air. Acta Paediatr 1998;87:82-87.
  23. Walsh MC, Wilson-Costello D, Zadell A, Newman N, Fanaroff A: Safety, reliability, and validity of a physiologic definition of bronchopulmonary dysplasia. J Perinatol 2003;23:451-456.
  24. Zhang S, Garbutt V, McBride JT: Strain-induced growth of the immature lung. J Appl Physiol (1985) 1996;81:1471-1476.
  25. Kubicka ZJ, Limauro J, Darnall RA: Heated, humidified high-flow nasal cannula therapy: yet another way to deliver continuous positive airway pressure? Pediatrics 2008;121:82-88.
  26. Locke RG, Wolfson MR, Shaffer TH, Rubenstein SD, Greenspan JS: Inadvertent administration of positive end-distending pressure during nasal cannula flow. Pediatrics 1993;91:135-138.
  27. Sreenan C, Lemke RP, Hudson-Mason A, Osiovich H: High-flow nasal cannulae in the management of apnea of prematurity: a comparison with conventional nasal continuous positive airway pressure. Pediatrics 2001;107:1081-1083.
  28. Singh S, Bowe L, Clarke P, Glover K, Pasquill A, Robinson M, Smith J: Is decreasing pressure or increasing time off the better strategy in weaning VLBW infants from nasal CPAP. Eur J Pediatr 2006;165:48.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: January 31, 2015
Accepted: June 25, 2015
Published online: August 28, 2015
Issue release date: November 2015

Number of Print Pages: 7
Number of Figures: 1
Number of Tables: 4

ISSN: 1661-7800 (Print)
eISSN: 1661-7819 (Online)

For additional information: https://www.karger.com/NEO


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP